Company Profile

Drug Discovery

Ordering Information



Duncan McBranch, Ph.D., Co-Founder and President
Before founding QTL, Dr. McBranch was the Team Leader of an R&D group of technical staff at Los Alamos National Laboratory. His research has focused on polymeric and nanostructured materials with advanced optical and electronic properties. In addition to his basic research interests, he led projects with industry partners to commercialize technology based on these new materials. He earned his Ph.D. in Physics from the University of California, Santa Barbara.

David Whitten, Ph.D., Co-Founder and Chief Technical Officer
Before founding QTL, Dr. Whitten managed R&D groups at Los Alamos National Laboratory, the University of Rochester, and the University of North Carolina. He was the founding Director of the NSF Center for Photoinduced Electron Transfer. He is currently Editor-in-Chief of Langmuir, and holds an adjunct Professorship at Arizona State University. He has extensive expertise in organic materials chemistry, including the photophysics and photochemistry of supramolecular systems.

Elisabeth LeQuin, MBA, CPA, Chief Financial Officer
Before December 2000, Ms. LeQuin has served as CFO for a number of small and medium-sized companies. Most recently, she was CFO for the U.S. Subsidiary of an international medical products company with ~$50 million in annual revenues, specializing in treatment tools for cancer. Ms. LeQuin has extensive experience in technology licensing, government contracting, manufacturing, mergers and acquisitions, and debt restructuring, as well as the fundamentals of financial management, audits, and tax issues.

The outside Directors bring a preeminent blend of biotechnology, software, and startup experience to the company. The Board provides an outlook across different high tech sectors of the U.S. both from a geographic and a product perspective. Additional members of the Board will consist of subsequent key investors and experts with knowledge considered critical to the success of the company.

Dr. Linda Wudl is a former Vice President for Quality Control, Quality Analytical Labs, and Compliance at Amgen Corporation, a leading international biotechnology and pharmaceutical company.

Eugene Bonte is an independent investor and consultant working with seed stage companies. From 1988 to 1999, he held senior management positions in two software companies; Object Design Inc.(later eXcelon Corporation) and Pegasystems Inc. (NASDAQ: PEGA) that went public during his tenure. .

Richard Troiano was the first employee of Cisco Systems, Inc. and later served as Director of European and Middle Eastern operations for Cisco. He currently is a co-founder and VP at XKL, LLC, manufacturer of a radically new generation of traffic shaping, IP routers.

David Soward is an investment banker representing Capital Partners, LLP.

Barry Johnson is an investor and represents Peter R. Harrison a U.K. technology entrepreneur.

Dr. Peter Heeger is an internationally recognized expert in immunology research and organ-transplant medicine, and is an Assistant Professor of Medicine at Case Western Reserve University.

Dr. Fred Wudl is a leading international authority on the synthesis and properties of conducting polymers, and is currently the Courtaulds Professor of Chemistry at the University of California, Los Angeles.

Dr. George McLendon is Chairman of the Department of Chemistry and currently the Russell Wellman Moore Proffessor of Chemistry at Princeton University. He is a leading authority in Protein-Protein; and Protein-Nucleic Acid recognition, Protein Engineering (site directed mutagenesis) and Electron Transfer in Chemical and Biological Systems.

Dr. Charles Turnbough is a Professor of Microbiology at University of Alabama, Birmingham.

Dr. Irena Bronstein is the founder and former CEO of Tropix, now a subsidiary of Applera corporation.

Dr. Alan J. Heeger is the founder and former President and CEO of Uniax Corporation in Santa Barbara, a high-tech company founded in 1990 to develop light-emitting displays based on conducting polymers. Uniax was acquired in March 2000 by Du Pont Corporation. Dr. Heeger is the 2000 Nobel Laureate in Chemistry for the discovery and development of conductive polymers. Currently Dr. Heeger is a Professor of Physics and Materials at the University of California, Santa Barbara.

Dr. Linda Wudl (see above)


Company Profile  |  Technology  |  Products  |  Drug Discovery  |  Biodefense  |  Careers  |  Ordering  |  FAQ's  |  Contact  |  Home
  © 2003 QTL Biosystems, LLC  |  All Rights Reserved